SCHEMBL70430

SCHEMBL70430

C1C[N]CCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL971638 0.93
SCHEMBL8528851 0.90
SCHEMBL7479673 0.88
SCHEMBL985 0.86
SCHEMBL1780973 0.82
Hydrochloric Acid SCHEMBL4420649 0.82
SCHEMBL7530365 0.82 TTR (0.50)
SCHEMBL8130613 0.82 TTR (0.50)
SCHEMBL233160 0.73
SCHEMBL11552939 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11993581-B2 Pyridazine compounds for inhibiting Nav1.8 LIEBER INSTITUE, INC (US) 2024-05-28 US claimed
WO-2024107393-A1 TRICYCLIC COMPOUNDS SCHRÖDINGER, INC. (US) 2024-05-23 WO claimed
EP-3852766-B1 COMBINATION THERAPY FOR TREATING BLOOD CANCER SIGNALCHEM LIFESCIENCES CORP (CA) 2024-05-08 EP claimed
CN-115003663-B Novel heteroaryl-triazole compounds as pesticides 拜耳公司 2024-04-30 CN claimed
EP-4276102-A2 PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS Printnet Kereskedelmi és Szolgáltató Kft. (HU) 2023-11-15 EP claimed
US-20230348453-A1 HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF IOMX THERAPEUTICS AG (DE) 2023-11-02 US claimed
US-11746112-B2 Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms EÖTVÖS LORÁND TUDOMÁNYEGYETEM (HU) 2023-09-05 US claimed
US-20230265103-A1 NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME TME THERAPEUTICS LLC 2023-08-24 US claimed
EP-3781263-B1 PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS PRINTNET KERESKEDELMI ES SZOLGALTATO KFT (HU) 2023-07-12 EP claimed
EP-4139305-A1 HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF iOmx Therapeutics AG (DE) 2023-03-01 EP claimed
US-20050026906-A1 Benzothiazole derivatives with actitvity as adenosine receptor ligands ALANINE ALEXANDER (FR) 2005-02-03 US claimed
EP-1465861-A1 ALPHA-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS BETA-AMYLOID INHIBITORS Bristol-Myers Squibb Company (US) 2004-10-13 EP claimed
US-20040127494-A1 Alpha-(N-sulfonamido)acetamide derivatives as beta-amyloid inhibitors BRISTOL-MYERS SQUIBB COMPANY 2004-07-01 US claimed
US-20030176695-A1 Benzothiazole derivatives with activity as adenosine receptor ligands ALANINE ALEXANDER (FR) 2003-09-18 US claimed
US-20030125318-A1 Benzothiazole derivatives with activity as adenosine receptor ligands ALANINE ALEXANDER (FR) 2003-07-03 US claimed
WO-2003053912-A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-07-03 WO claimed
EP-1303272-A2 BENZOTHIAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-04-23 EP claimed
US-20020045615-A1 Benzothiazole derivatives with activity as adenosine receptor ligands F.HOFFMANN-LA ROCHE AG (CH) 2002-04-18 US claimed
WO-2001097786-A2 BENZOTHIAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2001-12-27 WO claimed
US-4987130-A ANTIARRHYTHMIA AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1991-01-22 US claimed